Pengaruh Model Course Review Horay terhadap Hasil Belajar Fikih Siswa Madrasah Aliyah
Tasqif: Journal of Islamic Pedagogy · 31.07.2026 · 3 (2) · 58-72
DOI: 10.51590/tsqf.v3i2.98 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tasqif: Journal of Islamic Pedagogy, online erschienen am 31.07.2026. Verfasst von Muhammad Iqbal und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Limited variation in Fiqh teaching methods may reduce student engagement and learning outcomes. This study examined the effect of the Course Review Horay learning model on the Fiqh learning outcomes of eleventh-grade students at MAS Muhammadiyah 09 Sidomulyo, Langkat, North Sumatra. A quantitative quasi-experimental approach with a non-equivalent control group design was employed. Data were collected through pretests and posttests and analyzed using the Shapiro–Wilk normality test, homogeneity test, and Mann–Whitney U test. The results revealed a significant difference between the experimental and control groups, with the experimental group achieving higher learning outcomes. These findings indicate that the Course Review Horay model effectively improves Fiqh learning outcomes and can serve as an alternative strategy for creating a more active and engaging learning environment.
Zitieren
APA
Iqbal, M., & Manik, W. (2026). Pengaruh Model Course Review Horay terhadap Hasil Belajar Fikih Siswa Madrasah Aliyah. Tasqif: Journal of Islamic Pedagogy, 3(2), 58-72. https://doi.org/10.51590/tsqf.v3i2.98
Vancouver
Iqbal M, Manik W. Pengaruh Model Course Review Horay terhadap Hasil Belajar Fikih Siswa Madrasah Aliyah. Tasqif: Journal of Islamic Pedagogy. 2026;3(2):58-72. doi:10.51590/tsqf.v3i2.98
BibTeX
@article{Iqbal2026,
author = {Iqbal, Muhammad and Manik, Wagiman},
title = {Pengaruh Model Course Review Horay terhadap Hasil Belajar Fikih Siswa Madrasah Aliyah},
journal = {Tasqif: Journal of Islamic Pedagogy},
year = {2026},
volume = {3},
number = {2},
pages = {58--72},
doi = {10.51590/tsqf.v3i2.98}
}
EUVIMED